Anti-vascular endothelial growth factor strategies for the treatment of choroidal neovascularization from age-related macular degeneration

Int Ophthalmol Clin. 2004 Summer;44(3):23-32. doi: 10.1097/00004397-200404430-00005.

Authors

Fina C Barouch¹, Joan W Miller

Affiliation

¹ Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, 243 Charles Street, Boston, MA 02114, USA.

PMID: 15211174
DOI: 10.1097/00004397-200404430-00005

No abstract available

Publication types

Review

MeSH terms

Animals
Antibodies, Monoclonal / therapeutic use
Choroidal Neovascularization / drug therapy*
Choroidal Neovascularization / etiology
Choroidal Neovascularization / metabolism
Genetic Therapy
Humans
Macular Degeneration / complications
Macular Degeneration / drug therapy*
Macular Degeneration / metabolism
Oligonucleotides / therapeutic use
Vascular Endothelial Growth Factor A / antagonists & inhibitors*
Vascular Endothelial Growth Factor A / metabolism

Substances

Antibodies, Monoclonal
Oligonucleotides
VEGFA protein, human
Vascular Endothelial Growth Factor A